首页> 美国卫生研究院文献>BMC Cancer >Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

【2h】

Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

机译：转移性非小细胞肺癌（NSCLC）患者诊断时的提前肺癌炎症指数（ALI）是预后指标：回顾性回顾

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSystemic inflammation has been linked with cancer development, cancer cachexia and poor outcome. Advanced lung cancer inflammation index (ALI) was developed to assess degree of systemic inflammation at the time of diagnosis in metastatic non-small cell lung (NSCLC) cancer patients.

机译：背景系统性炎症与癌症发展，癌症恶病质和不良预后有关。发展先进的肺癌炎症指数（ALI）以评估转移性非小细胞肺癌（NSCLC）癌症患者诊断时的全身炎症程度。

著录项

期刊名称 BMC Cancer
作者
Syed H Jafri; Runhua Shi; Glenn Mills;
展开▼
作者单位

展开▼
年(卷),期 2013(13),-1
年度 2013
页码 158
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
Lung cancer Inflammation Neutrophil/lymphocyte ratio Advanced lung cancer inflammation index;

机译：肺癌;炎症;中性粒细胞/淋巴细胞比;晚期肺癌炎症指数;

相似文献

外文文献
中文文献
专利

1. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review [J] . Syed H Jafri, Runhua Shi, Glenn Mills BMC Cancer . 2013 ,第1期

机译：转移性非小细胞肺癌（NSCLC）患者诊断时的提前肺癌炎症指数（ALI）是预后指标：回顾性回顾
2. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. [J] . Berghmans T, Dusart M, Paesmans M, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008 ,第1期

机译：氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）测量的原发肿瘤标准化摄取值（SUVmax）对非小细胞肺癌（NSCLC）的生存具有预后价值：欧洲肺病的系统评价和荟萃分析（MA） IASLC肺癌分期项目的癌症工作组。
3. P2.03b-058 Blood Cell Count Ratios at Diagnosis as Prognostic Markers in Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC) [J] . Eliza Ricardo, Bianca Boneti, Taynan Ribeiro, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017 ,第1期

机译：P2.03B-058血液细胞计数诊断下作为转移性非小细胞肺癌患者的预后标志物（MNSCLC）
4. Enumeration and ALK Investigation of Circulating Tumor Cells in Non-Small Cell Lung Cancer (NSCLC) Patients Using an Effective In Vivo Technology, the GILUPI CellCollector? [C] . Klaus Luecke, Lukasz Gasiorowski, Stefanie Herold, International Molecular Medicine Tri-Conference. . 2015

机译：使用有效的体内技术（Gilupi Cellcollector
5. Use of Palliative Radiotherapy Among Metastatic Non-small-cell Lung Cancer (NSCLC) Patients in Puerto Rico [D] . ?Quinones Avila, Valerie 2020

机译：在波多黎各的转移性非小细胞肺癌（NSCLC）患者中使用姑息放射治疗
6. A Clinical Prognostic Score to Predict Survival of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Receiving First-Line Chemotherapy: A Retrospective Analysis [O] . Jing Gong, Ling Xu, Zhi Li, 1923

机译：预测一线化疗的晚期或转移性非小细胞肺癌（NSCLC）患者生存率的临床预后评分：回顾性分析
7. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review [O] . Syed H Jafri, Runhua Shi, Glenn Mills 2013

机译：转移性非小细胞肺癌（NSCLC）患者诊断时的提前肺癌炎症指数（ALI）是预后指标：回顾性回顾

Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

摘要

著录项

相似文献

相关主题

期刊订阅